Monica Feole

Monica Feole

Auto-generated profile, based on publicly available information

Monica Feole

International Clinical Research Center (ICRC) St. Anne's University Hospital Brno Czech Republic

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2022 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
VDVictorio Pozo Devoto
Victorio Pozo Devoto
VLValentina Lacovich
Valentina Lacovich
MFMonica Feole
Monica Feole
PBPratiksha Bhat
Pratiksha Bhat
JCJaroslav Chovan
Jaroslav Chovan
GSGorazd B. Stokin
Gorazd B. Stokin
Axonal swellings (AS) are one of the neuropathological hallmark of axonal injury in several disorders from trauma to neurodegeneration. Current evidence proposes a role of perturbed Ca2+ homeostasis in AS formation, involving impaired axonal transport and focal distension of the axons. Mechanisms of AS formation, in particular moments following injury, however, remain unknown. Here we show that AS form independently from intra-axonal Ca2+ changes, which are required primarily for the persistence of AS in time. We further show that the majority of axonal proteins undergoing de/phosphorylation immediately following injury belong to the cytoskeleton. This correlates with an increase in the distance of the actin/spectrin periodic rings and with microtubule tracks remodeling within AS. Observed cytoskeletal rearrangements support axonal transport without major interruptions. Our results demonstrate that the earliest axonal response to injury consists in physiological adaptations of axonal structure to preserve function rather than in immediate pathological events signaling axonal destruction.

5 March 2024 in Journal of Biological Chemistry
Verified
Journal Article
Open access
MFMonica Feole
Monica Feole
VDVictorio Pozo Devoto
Victorio Pozo Devoto
NDNeda Dragišić
Neda Dragišić
CACayetana Arnaiz
Cayetana Arnaiz
JBJulieta Bianchelli
Julieta Bianchelli
GSGorazd B. Stokin
Gorazd B. Stokin
Experimental studies in flies, mice, and humans suggest a significant role of impaired axonal transport in the pathogenesis of Alzheimer's disease (AD). The mechanisms underlying these impairments in axonal transport, however, remain poorly understood. Here we report that the Swedish familial AD mutation causes a standstill of the amyloid precursor protein (APP) in the axons at the expense of its reduced anterograde transport. The standstill reflects the perturbed directionality of the axonal transport of APP, which spends significantly more time traveling in the retrograde direction. This ineffective movement is accompanied by an enhanced association of dynactin-1 with APP, which suggests that reduced anterograde transport of APP is the result of enhanced activation of the retrograde molecular motor dynein by dynactin-1. The impact of the Swedish mutation on axonal transport is not limited to the APP vesicles since it also reverses the directionality of a subset of early endosomes, which become enlarged and aberrantly accumulate in distal locations. In addition, it also reduces the trafficking of lysosomes due to their less effective retrograde movement. Altogether, our experiments suggest a pivotal involvement of retrograde molecular motors and transport in the mechanisms underlying impaired axonal transport in AD and reveal significantly more widespread derangement of axonal transport pathways in the pathogenesis of AD.

30 July 2025 in bioRxiv
Verified
Preprint
Open access
JRJan Raska
Jan Raska
MSMiriam Satkova
Miriam Satkova
KPKlara Plesingrova
Klara Plesingrova
JSJiri Sedmik
Jiri Sedmik
SCSona Cesnarikova
Sona Cesnarikova
DBDáša Bohačiaková
Dáša Bohačiaková
Background: SORL1 , encoding the sorting receptor SORLA, is now recognized as the fourth autosomal dominant Alzheimer’s disease (AD) gene. Loss of SORLA function is known to disrupt endosomal trafficking and enhance amyloidogenic APP processing, two key aspects of the onset and progression of AD. However, the pathogenic consequences of disrupted endolysosomal pathways, deregulated protein sorting, as well as the effects of specific SORL1 missense variants on human neuronal function, still remain understudied. Methods: Our investigations were performed using two complementary human iPSC-derived models: 2D NGN2-induced neurons and 3D cerebral organoids established from isogenic wild-type (WT), SORL1 p.Y1816C (KI) missense variant, and SORL1 knock-out (KO) cells. We analyzed SORLA maturation and ectodomain shedding, APP localization, and amyloid-β secretion. Endosomal morphology and neuritic swellings were assessed via electron microscopy, while axonal transport of APP and Rab5+ endosomes was evaluated through live-cell imaging. Neuronal network activity was measured using multielectrode array recordings. Results: Our results demonstrate that the p.Y1816C variant leads to impaired SORLA maturation and reduced shedding, without affecting neuronal or organoid differentiation. Notably, we show an ultrastructure of endosomes, including their content, and demonstrate that both KO and KI models exhibit early endosome enlargement, increased APP retention in endosomes, elevated Aβ40/42 secretion, and amyloid-β deposition in 3D organoids. Importantly, we identified previously uncharacterized functional consequences of abolished SORLA activity, including axonal swellings and significantly impaired transport of Rab5+ endosomes and APP, characterized by deregulated velocities, directionality of transport, and increased stalling. Additionally, we discovered that both KO and p.Y1816C KI neurons exhibit abnormal electrophysiological activity, including increased spontaneous firing, burst frequency, and network synchrony. Conclusions: Our study defines the mechanistic consequences of the SORL1 p.Y1816C variant and demonstrates its pathogenicity in human neurons. Importantly, we also identify novel roles for SORLA in maintaining axonal transport homeostasis and regulating neuronal excitability, expanding its functional relevance beyond endosomal APP processing. These findings reinforce the central role of endosomal trafficking disruption in AD and support the use of isogenic human models for evaluating AD risk variants.

22 August 2026 in Alzheimer's & Dementia
Verified
Journal Article
Open access
MLMiriam Lep
Miriam Lep
KPKlara Plesingrova
Klara Plesingrova
JSJiri Sedmik
Jiri Sedmik
SCSona Cesnarikova
Sona Cesnarikova
MFMonica Feole
Monica Feole
JRJan Raska
Jan Raska
INTRODUCTION: SORL1 encodes the sorting receptor SORLA, a major genetic contributor to Alzheimer's disease (AD). Although SORL1 loss disrupts endosomal trafficking and promotes amyloidogenic amyloid precursor protein (APP) processing, the functional consequences of specific missense variants in human neurons remain unclear. METHODS: We used isogenic induced pluripotent stem cell (iPSC)‐derived NGN2 neurons and 3D cerebral organoids carrying wild‐type, SORL1 p.Y1816C knock‐in, or SORL1 knockout alleles. We analyzed SORLA maturation and shedding, APP localization, amyloid‐β (Aβ) secretion, endosomal morphology, axonal transport of Rab5+ endosomes and APP, and network activity. RESULTS: The p.Y1816C variant impaired SORLA maturation and shedding and, together with knockout, caused enlarged early endosomes, APP retention, elevated Aβ secretion, amyloid deposition in organoids, axonal swellings, disrupted axonal transport, and neuronal hyperexcitability. CONCLUSIONS: The SORL1 p.Y1816C variant is pathogenic in human neurons, and we reveal novel roles for SORLA in axonal transport and neuronal excitability. These findings highlight endosomal trafficking disruption as a central mechanism in AD pathogenesis.

16 June 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
MFMonica Feole
Monica Feole
VDVictorio Pozo Devoto
Victorio Pozo Devoto
NDNeda Dragisic
Neda Dragisic
MCMaria Carna
Maria Carna
KKKatja Klosterman
Katja Klosterman
GSGorazd Bernard Stokin
Gorazd Bernard Stokin
TDP-43 is an RNA-binding protein essential for RNA metabolism. Under physiological conditions, it predominantly resides in the nucleus but is also expressed in the cytoplasm, where it regulates mRNA trafficking and local translation. In nearly 97% of Amyotrophic Lateral Sclerosis (ALS) cases, TDP-43 undergoes nuclear depletion and cytoplasmic aggregation. While its nuclear functions are well characterized, its axonal roles remain poorly understood, despite axonal degeneration being a hallmark of ALS pathology. To address this gap, we investigated TDP-43 localization and transport dynamics in axons of H9-derived human neurons. We compared fluorescently labeled TDP-43 with three well-characterized axonal cargoes, Rab5, synaptophysin, and APP, and examined protein-protein interactions between TDP-43 and the axonal transport machinery. Our analyses revealed that TDP-43 exhibits active anterograde axonal transport and interacts with multiple kinesin motor proteins, including all three KIF5 isoforms, through the adaptor KLC1, and the synaptic vesicles motor KIF1A. This multi-motor engagement suggests a flexible transport system that ensures mRNA delivery to distal axons. In ALS, where TDP-43 accumulates abnormally in the cytoplasm, this flexibility may become compromised, with multiple transport mechanisms simultaneously affected. This could contribute to progressive accumulation of non-functional TDP-43 granules, disrupting mRNA trafficking and local translation. Our findings provide a foundation for understanding how physiological TDP-43 transport mechanisms may be impaired during disease, highlighting axonal TDP-43 transport pathways as potential therapeutic targets.

16 June 2023 in Alzheimer's & Dementia
Verified
Journal Article
Open access
VDVictorio Pozo Devoto
Victorio Pozo Devoto
VLValentina Lacovich
Valentina Lacovich
MFMonica Feole
Monica Feole
PBPratiksha Bhat
Pratiksha Bhat
GSGorazd B. Stokin
Gorazd B. Stokin
Background: Axonal swellings (AxS) are focal enlargements of axons found in a range of biological and pathological settings, including traumatic brain injury. However, the development of AxS and their early effects on axonal homeostasis are poorly understood. Here, we describe the cytoskeletal changes, transport effects and the molecular events that occur in the axon immediately after a traumatic injury.Method: We developed an in vitro system to study in real‐time the effects of traumatic injury on the axon of mature human neurons. We also generated an algorithm which allowed us to assess the dynamics of the AxS formation in real‐time and examine the role of Ca2+ in the swellings. Through mass spectrometry analysis on isolated axons we described the axonal proteome and identified the immediate phosphorylation changes ocurring in the axon after a traumatic injury. We also used superresolution microscopy to characterize the earliest cytoskeletal changes in the axon and their impact on the movement of several axonal cargoes.Result: As a result of the mechanical stress we observed the appereance of AxS, which were temporally correlated to Ca2+ levels increase in the axon. Interestingly, by pharmacologically blocking different sources of Ca2+ we observed that Ca2+ plays a role in sustaining the AxS and not in their formation. Proteomic and phosphoproteomic analysis revealed a significant regulation in proteins related to axon development after injury. These proteins were mainly interactors or components of the cytoskeleton, while no association to axonal degeneration or impairment in normal processes was found. We also predicted a general increase in kinases activity after injury, among them ROCK, ERK, JNK, PKC and GSK. A detailed analysis of cytoskeletal arrangement revealed modifications in the actin‐spectrin periodic structure and a mesh‐like organization of microtubules and neurofilaments in the AxS. We finally observed that the structure of swellings allows cargos to cross and that axonal transport of different cargos were not interrupted during mechanical stress.Conclusion: These observations indicate that the mechanical stress to the axon generates segments of cytoskeletal reorganization that result from Ca2+ increase and correlate with regulation through phosphorylation of cytoskeletal and cytoskeletal interacting proteins.